Skip to main content

Table 2 List of 35 key genes in four gene chips

From: Integrated transcriptomic analysis reveals hub genes involved in diagnosis and prognosis of pancreatic cancer

Gene

GSE28735

GSE15471

GSE16515

GSE101448

logFC

adj P

logFC

adj P

logFC

adj P

logFC

adj P

CTRL

−2.19

2.22E-5

−2.92

8.42E-4

−3.92

7.73E-3

−5.18

2.7E-22

SYCN

− 1.30

1.94E-4

−2.57

7.54E-3

−3.78

2.59E-2

−5.63

8.31E-21

PRSS3

−1.24

5.67E-4

−1.54

3.08E-2

−2.22

3.85E-2

−3.60

7.79E-12

CTRC

−2.61

4.62E-5

−1.56

8.09E-2

−3.40

3.93E-2

−3.45

3.77E-10

CELA2B

−2.21

1.12E-4

−2.38

8.13E-3

−3.42

1.53E-2

−4.38

1.08E-23

CEL

−2.51

1.36E-4

−1.27

1.86E-1

−3.51

3.85E-2

−3.52

1.61E-10

PNLIPRP1

−2.83

3.73E-5

−2.23

1.32E-2

−4.20

5.89E-3

−5.45

6.64E-14

CPA1

−1.87

1.39E-3

−1.27

2.22E-1

−3.33

7.09E-2

−4.96

3.24E-13

CPA2

−2.45

2.78E-4

−1.70

5.76E-2

−3.98

1.26E-2

−4.94

1.90E-14

GNMT

−1.41

1.77E-4

−2.85

1.03E-6

−3.07

3.94E-4

−4.83

5.59E-19

GATM

−1.46

7.98E-4

−0.93

8.45E-6

−2.72

1.23E-3

−3.08

1.52E-14

MAT1A

−0.80

2.28E-4

−1.50

9.31E-08

−1.41

6.06E-3

−1.27

8.05E-5

GCAT

−0.57

6.11E-4

−1.55

6.87E-7

−1.46

6.00E-

−2.48

1.11E-6

ABAT

−1.12

4.47E-7

−1.55

1.05E-6

−2.19

6.19E-5

−1.84

2.21E-14

GPT2

−0.87

1.20E-3

−1.43

5.99E-6

−1.48

1.56E-2

−2.13

1.86E-13

ADHFE1

−1.09

3.11E-8

−0.75

3.05E-8

−1.31

8.46E-7

−2.21

9.28E-11

PM20D1

−1.40

7.49E-5

−2.48

2.43E-7

−2.01

4.71E-3

−0.70

5.67E-3

PHGDH

−0.88

6.05E-5

−1.08

8.35E-7

−1.15

6.47E-3

−1.23

1.03E-6

PSAT1

−0.98

1.82E-3

−2.29

5.09E-8

−1.93

2.16E-3

−1.12

2.48E-5

BCAT1

−0.52

2.79E-2

−1.07

6.20E-3

−1.06

5.80E-2

−1.62

2.67E-8

PRDX4

−0.64

4.42E-4

−1.22

2.09E-6

−1.35

2.82E-4

−1.08

4.64E-2

ERP27

−2.50

2.31E-5

−2.28

2.08E-3

−3.42

5.15E-3

−4.16

2.57E-15

PDIA2

−2.12

7.91E-6

−1.43

1.11E-6

−3.48

1.06E-3

−5.23

1.38E-21

MT1H

−0.70

1.20E-5

−1.02

1.17E-5

−1.87

3.05E-6

−3.53

1.39E-17

MT1F

−1.00

4.95E-5

−1.23

3.68E-6

−1.86

8.16E-6

−2.32

1.79E-7

MT1G

−1.15

4.34E-5

−1.65

7.28E-8

−2.15

4.75E-6

−2.53

3.04E-10

COL5A1

0.77

4.83E-6

3.22

3.83E-15

1.81

1.71E-3

1.99

3.02E-8

COMP

1.44

1.47E-6

3.54

1.28E-14

2.17

5.19E-3

2.45

1.59E-7

CDH11

1.43

2.19E-7

2.55

8.28E-14

1.72

2.56E-3

2.20

5.03E-4

COL5A2

1.33

9.57E-6

3.54

1.69E-15

1.71

1.43E-3

1.74

8.66E-6

FN1

2.31

2.65E-10

2.80

2.66E-17

2.30

5.10E-6

1.45

4.92E-9

SULF1

1.94

9.20E-9

4.23

1.17E-19

2.56

6.86E-5

2.53

2.47E-6

COL1A2

1.58

7.27E-6

3.43

1.18E-16

1.68

7.98E-4

1.57

7.13E-11

FAP

1.44

1.44E-5

3.26

3.72E-16

1.84

4.73E-3

2.23

1.03E-6

POSTN

2.67

1.13E-10

2.94

1.58E-14

2.75

6.46E-5

3.08

1.76E-12

  1. logFC:log2(fold change) (tumor compared to normal tissue); adj P: adjusted P value
Back to article page

Molecular Medicine

ISSN: 1528-3658